Cellebrite DI Free Cash Flow (FCF) History (CLBT)

Cellebrite DI reported $160.3M in free cash flow for fiscal 2025, an increase of 29.70% from the previous fiscal year, with a free cash flow margin of 33.70%.

View full Cellebrite DI company overview

Cellebrite DI free cash flow by year

Cellebrite DI annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20252025-12-31$160.3M$36.7M+29.70%+33.70%
20242024-12-31$123.6M$26.8M+27.66%+30.81%
20232023-12-31$96.8M$83.1M+607.80%+29.78%
20222022-12-31$13.7M−$17.3M−55.79%+5.05%
20212021-12-31$30.9M−$29.4M−48.71%+12.57%
20202020-12-31$60.3M$50.4M+507.91%+30.95%
20192019-12-31$9.9M+5.77%

Cellebrite DI free cash flow growth trends

Over the last five reported fiscal years, free cash flow grew from $60.3M to $160.3M, a compound annual growth rate of 21.59%.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Cellebrite DI filings at SEC.gov ↗